Advanced imaging for oncology group
PET-CT, Sentinel lymph node biopsy, Oncology
Research aim
To enhance patient outcomes through improved cancer staging, enabling personalized treatments with advanced diagnostics.
About us
We are committed to improving patient outcomes through enhanced cancer staging that facilitates personalized treatments. Our focus on the latest PET tracers and imaging technologies, including AI, targets areas like head and neck cancer, thyroid cancer, and pediatric oncology, making diagnostics faster and more accurate. This matters greatly for effective treatment planning and patient care, particularly in reducing scan times for young patients and achieving precise staging. Our multidisciplinary team collaborates widely across specialties to address a broad spectrum of cancers comprehensively. Partnering with leading institutions and specialized groups, we drive innovations in cancer diagnosis and treatment, emphasizing collaboration and cutting-edge technology to advance patient care.